Healthcare · Healthcare Equipment & Supplies
QVM read Momentum-led Quality Weak, Valuation Fairly Valued, Momentum Bullish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #7 of 13 in Healthcare Equipment & Supplies by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 31 Mar 2025 | VIVEK GUPTA | Employee / designated person | Buy | 0 | ₹0 |
| 31 Mar 2025 | Saurabh Goyal | Promoter | Buy | 0 | ₹0 |
| 28 Mar 2025 | VIVEK GUPTA | Employee / designated person | Buy | 0 | ₹0 |
| 17 Mar 2025 | Aryan Goyal | Promoter group | Buy | 0 | ₹0 |
| 13 Mar 2025 | Aryan Goyal | Promoter group | Buy | 0 | ₹0 |
| 14 Feb 2025 | VIVEK GUPTA | Employee / designated person | Buy | 0 | ₹0 |
| 4 Feb 2025 | VIVEK GUPTA | Employee / designated person | Buy | 0 | ₹0 |
| 3 Feb 2025 | Saurabh Goyal | Promoter | Buy | 0 | ₹0 |
| 31 Jan 2025 | Saurabh Goyal | Promoter | Buy | 0 | ₹0 |
| 30 Dec 2024 | Aryan Goyal | Promoter group | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 29 Oct 2025 | SWATHITHA SIVAKUMAR | Bulk | Sell | 77,761 | 263.9600 | NSE |
| 15 Jan 2025 | COPTHALL MAURITIUS INVESTMENT LIMITED | Bulk | Buy | 116,711 | 401.9400 | NSE |
| 15 Jan 2025 | AAKRAYA RESEARCH LLP | Bulk | Sell | 63,937 | 409.8400 | NSE |
| 15 Jan 2025 | AAKRAYA RESEARCH LLP | Bulk | Buy | 63,937 | 409.4900 | NSE |
| 14 Jan 2025 | ELIXIR WEALTH MANAGEMENT PRIVATE LIMITED | Bulk | Sell | 65,679 | 363.9900 | NSE |
| 14 Jan 2025 | ELIXIR WEALTH MANAGEMENT PRIVATE LIMITED | Bulk | Buy | 51,679 | 360.2800 | NSE |
| 10 Jan 2025 | NK SECURITIES RESEARCH PRIVATE LIMITED | Bulk | Sell | 64,563 | 368.2200 | NSE |
| 10 Jan 2025 | NK SECURITIES RESEARCH PRIVATE LIMITED | Bulk | Buy | 64,563 | 367.8900 | NSE |
| 10 Jan 2025 | N V INVESTMENTS | Bulk | Buy | 158,000 | 358.8100 | NSE |
| 10 Jan 2025 | MUDUPULAVEMULA SURENDRANADHA REDDY | Bulk | Sell | 95,867 | 362.4100 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 24 Feb 2022 | Interim Dividend - Rs 3 Per Share | 3.0000 | 25 Feb 2022 |
| 21 Sep 2021 | Annual General Meeting/Dividend - Rs 2 Per Share | 2.0000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 12 Dec 2025 | BUYBACK | Buy Back |
| 11 Jul 2024 | OTHER | Annual General Meeting |
| 13 Jul 2023 | OTHER | Annual General Meeting |
| 1 Sep 2022 | OTHER | Annual General Meeting |
| 13 Jul 2022 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 21 Jul 2026 | Financial Results/Other business matters | Yes |
| 29 May 2026 | Financial Results/Other business matters | Yes |
| 17 Jan 2026 | Financial Results/Other business matters | Yes |
| 28 Nov 2025 | Buyback/Other business matters | — |
| 10 Nov 2025 | Buyback/Other business matters | — |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 1 Oct 2026 | Company Update | Nureca Ltd - 543264 - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 ('PIT Regulations') |
| 1 Oct 2026 | Updates | Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations )'. |
| 30 Sep 2026 | Company Update | Nureca Ltd - 543264 - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 ('PIT Regulations') |
| 30 Sep 2026 | Updates | Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations )'. |
| 29 Sep 2026 | Trading Window | Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 29 Sep 2026 | Updates | Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations )'. |
| 29 Sep 2026 | Insider Trading / SAST | Nureca Ltd - 543264 - Closure of Trading Window |
| 29 Sep 2026 | Company Update | Nureca Ltd - 543264 - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 ('PIT Regulations') |
| 28 Sep 2026 | Updates | Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations )'. |
| 28 Sep 2026 | Company Update | Nureca Ltd - 543264 - Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 ('PIT Regulations') |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
